[Digital arteriography using an intra-arterial route in vertebrobasilar insufficiency. Comparison of iopromide 300 and ioxaglate 320 mgI/ml].
During intra-arterial digital subtraction angiography of the vertebral and basilar arteries, 24 patients were included in a prospective double-blind randomized trial comparing a new non-ionic contrast medium, iopromide 300 and an ionic low osmolar medium, ioxaglate 320 mgI/ml. There was a statistically significant reduction in the number of adverse effects observed with Iopromide 300, particularly in terms of unwanted movements, source of image quality degradation.
Arnaud
O
O
Salamon
G
G
D015901:Angiography, Digital Subtraction; D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D014715:Vertebrobasilar Insufficiency / Q000000981:diagnostic imaging*
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D007485:Ioxaglic Acid
Artériographie numérisée par voie intra-artérielle dans l'insuffisance vertébro-basilaire. Comparaison de l'iopromide 300 et de l'ioxaglate 320 mgI/ml.